Endothelial cells (ECs) display marked phenotypic heterogeneity in structure and function, in time and space and in health and disease. Phenotypes differ between: 1) different segments of the vasculature (i.e., artery vs. vein vs. capillary); 2) different organs (i.e., lung capillary vs. heart capillary); and 3) neighboring cell (so-called mosaic heterogeneity). The mechanisms underlying the first two types of heterogeneity involve a combination of site-specific environmental signals (nurture) and vascular bed-specific epigenetic programs (nature). However, such mechanisms do not adequately explain mosaic heterogeneity of the endothelium, where phenotypically distinct neighbors have near-identical histories and environments. Mosaics of mutually exclusive phenotypes are observed across all domains of life. They are believed to arise from multistable regulatory circuits that are sensitive to biological noise. We propose that the normal endothelium leverages intrinsic noise-driven mosaic heterogeneity as a means of responding to opposing environmental demands with flexibility and speed. This ability to enhance its response repertoire (and hedge its bets) may be compromised in diseased or dysfunctional endothelium. The objective of this proposal is to use a combination of experimentation and modeling to delineate the mechanisms that govern mosaic heterogeneity of the endothelial-restricted procoagulant, von Willebrand factor (VWF), and to understand the adaptive significance of this phenomenon. We have shown that VWF expression is expressed in a minority of capillary ECs in heart, skeletal muscle, lung and brain and that this mosaic pattern is dynamically regulated. We have also observed dynamic mosaic heterogeneity of VWF in cultured primary human ECs. Surprisingly, we found that the bistable switch responsible for mosaic VWF expression involves noise-sensitive DNA methylation of the VWF promoter. Finally, and most importantly, our preliminary data indicate that the absence of mosaic VWF expression in the heart leads to profound endothelial damage. Based on these findings, we hypothesize that organ-specific mosaic heterogeneity of VWF is mediated by a cell-autonomous, bistable DNA methylation switch, whose sensitivity to noise is modulated by its extracellular and intracellular environment. We further hypothesize that mosaic VWF heterogeneity is required for cardiac health. Our goal is to measure, model and predict the behavior of this switch and to delineate the mechanisms by which mosaic heterogeneity promotes cardiac health. We propose three specific aims. In the first aim, we will delineate the role of biological noise in generating VWF mosaic heterogeneity. In the second aim, we will delineate the molecular basis of the bistable switch underlying VWF mosaic heterogeneity. In the third aim, we will delineate the role of VWF mosaic heterogeneity in cardiac health. The project is significant because it establishes a foundation for testing the hypothesis that dynamic mosaic heterogeneity of the endothelium provides a means for tunable, organ-specific bet hedging. Such behavior has important therapeutic implications for treating vascular diseases.

Public Health Relevance

Mosaic heterogeneity of the endothelium is a poorly understood phenomenon. An understanding of the dynamics and molecular mechanisms of mosaic heterogeneity should provide new insights into how the endothelium responds to opposing environmental demands with flexibility and speed, and how this process may become disrupted in vascular disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL119322-03
Application #
9271086
Study Section
Vascular Cell and Molecular Biology Study Section (VCMB)
Program Officer
Gao, Yunling
Project Start
2015-07-01
Project End
2019-04-30
Budget Start
2017-05-01
Budget End
2018-04-30
Support Year
3
Fiscal Year
2017
Total Cost
$435,000
Indirect Cost
$185,000
Name
Beth Israel Deaconess Medical Center
Department
Type
Independent Hospitals
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02215
Beeler, D L; Aird, W C; Grant, M A (2018) Evolutionary conservation of the allosteric activation of factor VIIa by tissue factor in lamprey. J Thromb Haemost 16:734-748
Grant, Marianne A; Beeler, David L; Spokes, Katherine C et al. (2017) Identification of extant vertebrate Myxine glutinosa VWF: evolutionary conservation of primary hemostasis. Blood 130:2548-2558
Deritei, Dávid; Aird, William C; Ercsey-Ravasz, Mária et al. (2016) Principles of dynamical modularity in biological regulatory networks. Sci Rep 6:21957
Yuan, Lei; Chan, Gary C; Beeler, David et al. (2016) A role of stochastic phenotype switching in generating mosaic endothelial cell heterogeneity. Nat Commun 7:10160